MoneyWorks4Me

Lupin reports over four-fold rise in Q1 net

24 Jul 2012 Evaluate

Lupin has reported results for first quarter ended June 30, 2012.

On standalone basis, the company has posted a rise of 391.04% in its net profit at Rs 357.23 crore for the quarter ended June 30, 2012 as compared to Rs 72.75 crore for the same quarter in the previous year. Total income has increased by 61.01% at Rs 1780.29 crore for quarter under review as compared to Rs 1105.71 crore for the quarter ended June 30, 2011.

On consolidated basis, the company has posted a rise of 33.47% in its net profit at Rs 280.39 crore for the quarter ended June 30, 2012 as compared to Rs 210.08 crore for the same quarter in the previous year. Total income has increased by 43.78% at Rs 2253.74 crore for quarter under review as compared to Rs 1567.53 crore for the quarter ended June 30, 2011.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..